Pyrimidine nucleobase biosynthetic process

pathway activity — cross-omics
GO:0019856Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine nucleobase biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are LDB3, XPA, and ZBTB22, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine nucleobase biosynthetic process activity versus LDB3 in LUAD (Pearson r = -0.20).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADLDB3 →-0.299-0.130.001.00435
BRCAXPA →-0.424-0.181<.001.00235
BRCAZBTB22 →-0.276-0.128.007.00635
OVARHGEF15 →-0.521-0.153.003.00135
LUADPAOX →-0.195-0.166.008.00434
CCRCCEHD4-AS1 →-0.317-0.093.003.00334
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0019856 vs LDB3 — LUAD

Per-sample scatter of Pyrimidine nucleobase biosynthetic process activity vs LDB3 in LUAD.

Explore this scatter interactively →

Exploration